NCT00614757

Insulin Resistance Study

The Prevalence of Insulin Resistance and the Potential Modulation of Insulin Resistance by N-acetylcysteine (NAC) in Patients Chronically Infected by the Hepatitis C Virus

• Status: Suspended
• Phase: N/A
• Study type: Interventional
• Enrollment: 121 (actual)
• Sponsor: Midwest Biomedical Research Foundation · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate how often patients with hepatitis C infection have abnormalities of sugar and fat utilization. Additionally we would like to find out if these abnormalities of sugar and fat utilization are common in other liver diseases, or related to being overweight.

Conditions

• Insulin Resistance
• Metabolic Syndrome x

Interventions

Type	Name	Description
DRUG	N-acetylcysteine 20% 4ml	N-acetylcysteine 20% 4ml
DRUG	N-acetylcysteine 20% in 4 ml	N-acetylcysteine 20% in 4 ml

Timeline

• Start date: 2005-05-01
• Primary completion: 2013-12-01
• Completion: 2013-12-01
• First posted: 2008-02-13
• Last updated: 2012-10-26

Locations

1 site across 1 country: United States